SK bioscience, a global innovative vaccine and biotech company, signed a research collaboration agreement with the Doherty Institute for influenza research. Under this agreement, SK bioscience and the Doherty Institute will work together to further research influenza biology, vaccines, and antivirals. The program will include testing of anti-influenza compounds to identify new antivirals, capacity building in low- and middle-income countries of the region, and the development of a new influen...